Information Provided By: 
Fly News Breaks for February 7, 2020
CAH
Feb 7, 2020 | 07:56 EDT
As reported previously, Baird analyst Eric Coldwell upgraded Cardinal Health to Outperform from Neutral. He acknowledged his upgrade is something of a contrarian call on an inflection in U.S. Distribution macro, company-specific self-help initiatives, and low valuation. He said risks are high with Cardinal Health but his upgrade is more of a sector call. Coldwell raised his price target to $68 from $54 on Cardinal Health shares.
News For CAH From the Last 2 Days
